Skip to main content

Table 4 Relationship between types of residual tumors and the expression changes

From: Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors

Receptor

Change

Type of residual tumor

  

Type I

Type II

Type III

P valuea

ER

Increase

2

2

0

0.839

No change

41

20

4

Decrease

12

8

1

PR

Increase

6

3

0

0.891

No change

36

20

4

Decrease

13

7

1

HER2

Increase

6

2

1

0.545

No change

36

22

4

Decrease

13

6

0

  1. aJonckheere-Terpstra test.